Roche’s COVID-19 antibody test receives FDA Emergency Use Authorization and is available in markets accepting the CE mark

  • The serology test has a specificity greater than 99.8% and sensitivity of 100% (14 Days post-PCR confirmation)
  • The high specificity of the test is crucial to determine reliably if a person has been exposed to the virus and if the patient has developed antibodies
  • Roche will provide high double-digit millions of tests already in May for countries accepting the CE mark and in the U.S. under Emergency Use Authorization, further ramping up capacities thereafter
  • The test is available on Roche’s cobas e analysers which are widely available around the world 

Continue reading

Library of training and product resources for medical professionals created through a partnership between ventilator manufacturers

Created through a partnership between ventilator manufacturers, including Dräger, GE Healthcare, Getinge, Hamilton Medical, Medtronic, Nihon Kohden, Philips, and other manufacturers and powered by Allego, the central the central knowledge hub provides free mobile access to video tutorials, instruction manuals, and other training materials for equipment that is critical to helping clinicians treat patients suffering from COVID-19 related respiratory distress. Manufacturers are responsible for their own content. Continue reading

COVID-19 – How What You Flush Can Help Scientists Measure Community Health

Fighting Coronavirus/COVID-19 with Public Health Data

The City of Tempe and Arizona State University are working together to study wastewater as a strategy to advance community health. Tempe is in a unique position for an innovative response to the coronavirus/COVID-19 pandemic due to the Wastewater Data Analytics – Opioids program supported by the Tempe City Council’s Innovation Fund in 2018 and the community trust cultivated by the city’s compassion, science and services approach in using public health data. Continue reading

CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission

Rapid release of open coronavirus sequence data will help guide COVID-19 public health response, drive innovation and discovery, and advance understanding of this and future pandemics.

The SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES) consortium, which will greatly expand the use of whole genome sequencing (WGS) of the COVID-19 virus.  Consortium members include Northern Arizona University, TGen, and the State of Ariona.

Continue reading